MRVI logo

Maravai LifeSciences Holdings (MRVI) Revenue

Annual Revenue

$288.94 M
-$594.06 M-67.28%

31 December 2023

MRVI Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$65.20 M
-$8.20 M-11.17%

30 September 2024

MRVI Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$276.92 M
-$1.67 M-0.60%

30 September 2024

MRVI TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MRVI Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-67.3%-2.5%-34.0%
3 y3 years+1.7%-68.2%-58.6%
5 y5 years+133.3%--

MRVI Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-67.3%+1.7%-73.3%+1.6%-69.9%+1.0%
5 y5 years-67.3%+133.3%-73.3%+81.3%-69.9%+670.1%
alltimeall time-67.3%+133.3%-73.3%+81.3%-69.9%+670.1%

Maravai LifeSciences Holdings Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$65.20 M(-11.2%)
$276.92 M(-0.6%)
June 2024
-
$73.40 M(+14.4%)
$278.58 M(+1.6%)
Mar 2024
-
$64.18 M(-13.4%)
$274.10 M(-5.1%)
Dec 2023
$288.94 M(-67.3%)
$74.14 M(+10.9%)
$288.94 M(-31.1%)
Sept 2023
-
$66.86 M(-3.0%)
$419.52 M(-22.9%)
June 2023
-
$68.91 M(-12.8%)
$543.91 M(-24.2%)
Mar 2023
-
$79.03 M(-61.4%)
$717.73 M(-18.7%)
Dec 2022
$883.00 M
$204.71 M(+7.0%)
$883.00 M(-2.6%)
Sept 2022
-
$191.26 M(-21.2%)
$906.73 M(-1.5%)
June 2022
-
$242.73 M(-0.6%)
$920.28 M(+2.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
$244.29 M(+6.9%)
$895.32 M(+12.0%)
Dec 2021
$799.24 M(+181.3%)
$228.44 M(+11.5%)
$799.24 M(+19.4%)
Sept 2021
-
$204.81 M(-6.0%)
$669.15 M(+21.2%)
June 2021
-
$217.78 M(+46.9%)
$552.20 M(+44.8%)
Mar 2021
-
$148.21 M(+50.7%)
$381.33 M(+34.2%)
Dec 2020
$284.10 M(+98.5%)
$98.35 M(+11.9%)
$284.10 M(+28.1%)
Sept 2020
-
$87.86 M(+87.3%)
$221.71 M(+65.6%)
June 2020
-
$46.91 M(-8.0%)
$133.85 M(+54.0%)
Mar 2020
-
$50.98 M(+41.8%)
$86.94 M(+141.8%)
Dec 2019
$143.14 M(+15.6%)
$35.96 M
$35.96 M
Dec 2018
$123.83 M
-
-

FAQ

  • What is Maravai LifeSciences Holdings annual revenue?
  • What is the all time high annual revenue for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings annual revenue year-on-year change?
  • What is Maravai LifeSciences Holdings quarterly revenue?
  • What is the all time high quarterly revenue for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings quarterly revenue year-on-year change?
  • What is Maravai LifeSciences Holdings TTM revenue?
  • What is the all time high TTM revenue for Maravai LifeSciences Holdings?
  • What is Maravai LifeSciences Holdings TTM revenue year-on-year change?

What is Maravai LifeSciences Holdings annual revenue?

The current annual revenue of MRVI is $288.94 M

What is the all time high annual revenue for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high annual revenue is $883.00 M

What is Maravai LifeSciences Holdings annual revenue year-on-year change?

Over the past year, MRVI annual revenue has changed by -$594.06 M (-67.28%)

What is Maravai LifeSciences Holdings quarterly revenue?

The current quarterly revenue of MRVI is $65.20 M

What is the all time high quarterly revenue for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high quarterly revenue is $244.29 M

What is Maravai LifeSciences Holdings quarterly revenue year-on-year change?

Over the past year, MRVI quarterly revenue has changed by -$1.67 M (-2.49%)

What is Maravai LifeSciences Holdings TTM revenue?

The current TTM revenue of MRVI is $276.92 M

What is the all time high TTM revenue for Maravai LifeSciences Holdings?

Maravai LifeSciences Holdings all-time high TTM revenue is $920.28 M

What is Maravai LifeSciences Holdings TTM revenue year-on-year change?

Over the past year, MRVI TTM revenue has changed by -$142.60 M (-33.99%)